Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV1 in primary care patients presenting with a persistent cough?

Thorax

Volumn 54, Issue 12, 1999, Pages 1055-1060

  Thiadens, H A ^a   De Bock, G H ^a   Van Houwelingen, J C ^a   Dekker, F W ^b   De Waal, M W M ^a   Springer, M P ^a   Postma, D S ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Airflow obstruction; Asthma; Chronic obstruction pulmonary disease; Diagnosis; General practice; Peak expiratory flow

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIAGNOSTIC ACCURACY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPIROMETRY;

EID: 0032751103     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.12.1055     Document Type: Article

References (19)

1. Cross D, Nelson HS. The role of the peak flow meter in the diagnosis and management of asthma. J Allergy Clin Immunol 1991;87:120-8.
2. Jones K, Lane D, Holgate ST, et al. Asthma: A diagnostic and therapeutic challenge. Family Pract 1991;8:97-9.
3. National Heart, Lung and Blood Institute. International consensus report on diagnosis and management of asthma. Eur Respir J 1992;5:601-41.
4. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Publication No. 95-3659. NHLBI/ WHO Workshop Report. Bethesda: National Institutes of Health, National Heart, Lung, and Blood Institute, 1995.
5. Quanjer PhH, Lebowitz MD, Gregg I, et al. Peak expiratory flow. Conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997;10(Suppl 24):2-8.
6. 1, and peak expiratory flow in patients with chronic airflow obstruction. Thorax 1988;43:335-6.
7. 1. Eur Respir J 1997;10(Suppl 24):42-4.
8. Dekker FW, Schrier AC, Sterk PJ, et al. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992;47:162-6.
9. Thiadens HA, De Bock GH, Dekker FW, et al. Identifying asthma and chronic obstructive pulmonary disease in patients with persistent cough presenting to general practitioners: Descriptive study. BMJ 1998;316:1286-90.
10. Thiadens HA, De Bock GH, Dekker FW, et al. The value of measuring diurnal peakflow variability in the recognition of asthma. Eur Respir J 1998;12:842-7.
11. Quanjer PhH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flow. Eur Respir J 1993;6(Suppl 16):5-10.
12. Brand PLP, Quanjer PhH, Postma DS, et al and the Dutch CNSLD Study Group. Interpretation of bronchodilator response in patients with obstructive airways discase. Thorax 1992;47:429-36.
13. Dales RE, Spitzer WO, Toussignant P, et al. Clinical interpretation of airway response to a bronchodilator. Am Rev Respir Dis 1998;138:317-20.
14. 1, and smoking habits. Thorax 1984;39:928-32.
15. COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl 5):S1 28.
16. Godschalk I, Brackel IIJL, Peters JCK, et al. Assessment of accuracy and applicability of a portable electronic diary card spirometer for asthma treatment. Respir Med 1996;90:619-22.
17. Sears MR. The definition and diagnosis of asthma. Allergy 1993;48:12-6.
18. Nicklaus TM, Burgin WW Jr, Taylor JR. Spirometric tests to diagnose suspected asthma. Am Rev Respir Dis 1969;100: 153-9.
19. Weinstein MC, Fineberg HV. Clinical Decision Analysis. Philadelphia: WB Saunders, 1980:83.